AdvanDx Adds QuickFISH Enterococcal Bacteremia Assay
AdvanDx, Inc. have launched Enterococcus QuickFISH BC, a new rapid molecular diagnostic test that identifies potentially life threatening bloodstream infections caused by Enterococcus. This new QuickFISH assay is immediately available and complements the September 2012 launch of Staphylococcus QuickFISH BC for the identification of Staphylococcus aureus and coagulase-negative staphylococci. With these new products, QuickFISH can now be used to identify the causative pathogens of approximately 70% (Ann Clin Microbiol Antimicrob. 2004 May 10;3:7) of hospital acquired infections from blood cultures.
Enterococcus species are the fourth most common cause of hospital-acquired bacteremia in the U.S. and fifth most common in Europe. The vast majority of enteroccocal infections are caused by Enterococcus faecalis and Enterococcus faecium. Treatment decisions are difficult because these species exhibit differing antibiotic resistance profiles. While E. faecalis is generally susceptible to ampicillin, infections caused by other enterococci, mainly E. faecium, are often resistant to ampicillin or vancomycin, or both. Conventional identification methods can take up to 3 days or longer, and patients with E. faecium bloodstream infections often receive inappropriate antimicrobial therapy for days, leading to higher mortality and significant hospital costs. With this new test, clinicians may prescribe earlier and more appropriate therapy for enterococcal infections. QuickFISH marks a significant advance in time-to-result and ease-of-use that will help clinicians, hospital pharmacists and clinical microbiologists optimize antibiotic therapy much earlier for patients with bloodstream infections.
QuickFISH is a new, rapid, molecular diagnostic platform developed by AdvanDx based on its clinically proven proprietary PNA technology. The new platform enables unprecedented (20 minute) species identification of bacteria directly from positive blood cultures allowing the reporting of pathogen identification at the same time as the reporting of Gram stain results.
- 5 Minute Hands-on Time - Simplifies and streamlines laboratory workflow.
- 20 Minute Turn-around Time - Fast enough to be reported with Gram stain results.
- Built-in, Universal Controls - Ensures confidence in test results.
- Limited Instrumentation and Capital Investment Required - Easy and inexpensive to implement and start testing.
Tags: Blood Culture, Identification, Enterococci, Stains, Staphylococcus aureus, Pathogen, Enterococcus, Staphylococcus
Date Published: January 14, 2013 » company contact details
Explore Charles River Microbial Solutions Extensive QC Micro Portfolio
Tecta-PDS Enterococci Test Delivers Rapid, Automated Results for Water
12th Annual PDA Global Conference on Pharmaceutical Microbiology
Hygiena Expands Testing Portfolio to Cover Entire Contamination Detection Spectrum
IDbyDNA and ARUP Laboratories to Develop NGS Tests